Lamotrigine Milpharm (Lamotrigine)

Lamotrigine works by inhibiting voltage‑gated sodium channels, which stabilises neuronal membranes and reduces the release of excitatory neurotransmitters such as glutamate. This action diminishes abnormal neuronal firing that contributes to seizures and mood instability.

The dose of Lamotrigine Milpharm is determined by the prescribing clinician based on the patient’s specific condition, age, renal and hepatic function, and response to therapy. Dosage titration follows established clinical guidelines to balance efficacy and safety.

Lamotrigine’s pregnancy category is listed as unknown, and safety data are limited. Healthcare providers must weigh the potential benefits for the mother against possible risks to the fetus. Breastfeeding decisions should also be made in consultation with a medical professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with many older anticonvulsants, lamotrigine offers a favourable side‑effect profile and is effective for both seizure control and mood stabilization. However, it requires careful titration to minimise rash risk, and drug‑interaction potential differs, especially with enzyme‑inducing agents.

Lamotrigine Milpharm should be stored at room temperature, below 25 °C, in its original packaging. Protect the tablets from moisture, excessive heat and direct sunlight to maintain potency throughout the shelf‑life.

Lamotrigine Milpharm is taken orally, usually with or without food, as directed by the prescriber. Tablets are swallowed whole with a glass of water, and the dosing schedule is adjusted during the titration phase to reduce rash risk.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, blood dyscrasias like agranulocytosis, hepatic failure, and the emergence of suicidal thoughts. Immediate medical attention is required if any of these symptoms appear.

Lamotrigine Milpharm is contraindicated in individuals with a known hypersensitivity to lamotrigine or any of its excipients. Caution is also advised for patients with severe hepatic impairment, a history of serious skin reactions, or those taking interacting medications without proper monitoring.